About: Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on August 2010

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2010 (ast) наукова стаття, опублікована в серпні 2010 (uk) مقالة علمية نشرت في أغسطس 2010 (ar) scientific article published on August 2010 (en)
publication date	wds:Q37507270-2F120EEC-6EF5-4CE8-A2A2-C942A620B801
publication date	2010-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37507270-E28E1901-E4FA-470D-AC0B-6AB7FC635219
language of work or name	English
cites work	wds:Q37507270-052B12BD-71C1-4C77-BA0F-24DF4ECFAA1D wds:Q37507270-303196C5-8731-4944-ACF3-755B8B3F7BE3 wds:Q37507270-4153C57F-B487-4D07-BA6D-AC79E8201319 wds:Q37507270-41811FC1-2454-45F5-B01D-99C380B02895 wds:Q37507270-58F42786-C043-45C1-B50D-204F9C902493 wds:Q37507270-6B4C7A7E-2CB6-4452-8534-91E5950048CC wds:Q37507270-6E3B82D1-3651-4C7B-AC98-254407F35D1D wds:Q37507270-78988A4F-430C-44FB-AA42-3007E1111D2F wds:Q37507270-7DC7CE37-90FA-4E96-90EC-F83A8724EC0D wds:Q37507270-889C36C3-DC16-4DBB-801A-5E06FD0BBC60 wds:Q37507270-89824BC4-4863-4FF4-AB57-D315F8C2B183 wds:Q37507270-B1A62C89-EF91-4524-9163-73C979BB7EA2 wds:Q37507270-B5728DAA-4991-4324-9F3F-38C4A1BF12DB wds:Q37507270-D25AE2B4-E3C3-44E0-8FE6-B546E9B75016 wds:Q37507270-D5812FF4-1E15-424E-A296-08CC3EB6D5DB wds:Q37507270-DE806BC1-A349-4A17-9917-40AF2F3B6D97 wds:Q37507270-E42C3F69-9DFC-43A6-834E-FBBAA7F53D25 wds:Q37507270-ED339F15-6AA7-412C-942A-85539E542758 wds:Q37507270-F95B34AF-D581-4E3E-82E9-F5DF502C37B3
cites work	Targeting multidrug resistance in cancer Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer A predictive toxicological paradigm for the safety assessment of nanomaterials. Mechanisms of cancer drug resistance Cancer nanotechnology: opportunities and challenges Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs Multi-functional nanocarriers to overcome tumor drug resistance The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. TAT conjugated, FITC doped silica nanoparticles for bioimaging applications. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs Mechanised nanoparticles for drug delivery Light-activated nanoimpeller-controlled drug release in cancer cells Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer. Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding
author name string	wds:Q37507270-14E1B361-6E93-41CF-83D3-4D73C2465C73 wds:Q37507270-6322CAAA-445E-4393-B006-6CEB7E88A774 wds:Q37507270-7189E6C9-9228-42BB-8A5D-067E07D19698 wds:Q37507270-88F6C5BE-97CF-45A5-9A2B-D151044E16B6 wds:Q37507270-95BDDB16-3A9D-4CD7-9D6D-76CDFAD35EFA wds:Q37507270-BBC16983-A539-4078-A345-1AEAC4152521
author name string	Huan Meng Zhaoxia Ji Andre E Nel Jeffrey I Zink Monty Liong Zongxi Li
rdfs:label	Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line (en) Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line (nl) Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line (ast)
skos:prefLabel	Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line (en) Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line (nl) Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line (ast)
name	Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line (en) Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line (nl) Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line (ast)
author	wds:Q37507270-AECA17FA-04A1-44D3-8A02-CF456DD5EE56
author	Tian Xia
title	wds:Q37507270-C75F4B74-54D7-4B06-99BB-9C8451DC025C
title	Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line (en)
page(s)	wds:Q37507270-D2DBEB29-700A-4DCC-B4C6-02211E19B6EE
page(s)	4539-4550
instance of	wds:Q37507270-3A39B534-8E3F-46F6-A499-39D4E537F667
instance of	scholarly article
main subject	wds:Q37507270-0BAF00ED-5641-4033-B125-7B72BAB76EB1 wds:Q37507270-1F8C1413-DD22-4D56-91A5-F30C6D212DC7 wds:Q37507270-8B07903D-961A-4BC4-8861-B5634649C3B2 wds:Q37507270-D8110CB6-6C27-49CA-A03A-D92CE902E36A wds:Q37507270-F3043B01-C85D-409F-8F2D-748CDE2B8A55
main subject	wd:Q18936 nanoparticle cell line cancer cell line RNA design
PubMed ID	wds:Q37507270-E2A46831-59B7-415A-9CA4-3E6F6F1D7495
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20731437

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software